Answers are grounded in this paper and cite their sources.
Fluorescent sensor arrays have evolved from laboratory-based analytical tools into powerful multidimensional platforms capable of decoding the complexity of biological systems. By combining diverse sensing elements including nanoparticles, organic fluorophores, supramolecular systems, and polymers with pattern-based analysis, these arrays generate information-rich response patterns for distinguishing complex analytes. In response to the increasing demands of clinical diagnostics, the field has shifted from proof-of-concept studies in artificial or spiked media toward the direct analysis of clinically derived samples. Here, we bring together the still small but growing body of literature in which fluorescent sensor arrays have been successfully applied to patient-derived fluids and tissues. The studies are organized by biological matrix and analyte class, highlighting applications for small-molecule biomarkers, proteins, bacteria, and clinical isolates. We examine the range of multivariate analysis strategies employed, from classical methods to modern machine learning approaches enabling quantitative analysis. While most reported systems focus on qualitative discrimination, we discuss the growing need for robust quantification and the challenges associated with clinical translation, including validation, reproducibility, and integration into healthcare workflows. By consolidating these advances, we provide a timely perspective on the current state of the field and highlight the key steps required to realize the potential of fluorescent sensor arrays in illuminating complex biological information for routine medical decision-making.
No takes yet. Share an insight, caveat, or question.
Grover et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: